Lacosamide Injection
Product Images NDC 72205-220

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72205-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lac-inj-carton-label (Lac Inj Carton Label)

Packaging label for Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) intravenous injection by Novadoz Pharmaceuticals LLC. The box contains 10 single-dose vials of 20 mL each. The label includes dosage strength, route of administration, distributor information, and instructions for pharmacists to dispense a medication guide with each vial.*

FDA Label Image

Lac-inj-fig-1 (Lac Inj Fig 1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' showing seizure reduction percentages across four studies comparing placebo and lacosamide doses. The x-axis lists placebo and various lacosamide doses, while the y-axis indicates seizure reduction percentage, demonstrating higher reductions with lacosamide than with placebo.*

FDA Label Image

Lac-inj-fig-2 (Lac Inj Fig 2)

A line graph titled 'Figure 2 – Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4.' The y-axis represents Responder Rate (equal to or greater) ranging from -100% to 100%, and the x-axis represents Percent of Patients from 0 to 100. The graph shows four lines comparing placebo and three dosages of Lacosamide (200 mg/day, 400 mg/day, and 600 mg/day) illustrating patient response rates.*

FDA Label Image

Lac-inj-structure (Lac Inj Structure)

Chemical structure of lacosamide, showing the molecular arrangement including an amide group, ether linkage, and benzyl group consistent with its chemical identity.*

FDA Label Image

Lac-inj-vial-label (Lac Inj Vial Label)

Label for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL) for intravenous use, packaged as a 20 mL single-dose vial. The label includes storage instructions, inactive ingredients, manufacturer information (MSN Laboratories Private Limited, India), and distributor details (Novadoz Pharmaceuticals LLC). The product is Rx only with an NDC 72205-220-01 barcode present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.